Paper32004792
Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used.
Ogata D and 20 others. Eur J Cancer, 2020. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used. Papers, record 32004792. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32004792
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Systemic treatment of patients with advanced cutaneous squamous cell carcinoma: response rates and outcomes of the regimes used.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Chemoradiotherapy | Major topic |
| Cisplatin | Major topic |
| Radiotherapy | Major topic |
| Skin Neoplasms | Major topic |
| Adult | |
| Aged | |
| Aged, 80 and over | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Male | |
| Middle Aged | |
| Prognosis | |
| Retrospective Studies | |
| Survival Rate |
Source PubMed
Cited by11
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41957579 | CDKN2A, ITGA3, SMAD4 and SIRT7 gene expression in human cutaneous squamous cell carcinoma development and pre-clinical diagnosis. | BMC Cancer | 2026 | https://conductscience.org/library/papers/41957579 | PubMed |
| 41681926 | A Real-World Experience of Cemiplimab in Patients with Advanced Cutaneous Squamous Cell Carcinoma. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/41681926 | PubMed |
| 39779554 | Targeting PD-1 in Squamous Cell Carcinoma: Flavonoid-based Therapeutics Unveiled through in silico and in vitro Approaches. | Curr Comput Aided Drug Des | 2026 | https://conductscience.org/library/papers/39779554 | PubMed |
| 39582977 | KS-cSCC-1 and KS-cSCC-2: two novel cutaneous squamous cell carcinoma cell lines established from Japanese patients. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39582977 | PubMed |
| 38756868 | Metastatic patterns and treatment options for head and neck cutaneous squamous cell carcinoma (Review). | Mol Clin Oncol | 2024 | https://conductscience.org/library/papers/38756868 | PubMed |
| 36844955 | Classic and new strategies for the treatment of advanced melanoma and non-melanoma skin cancer. | Front Med (Lausanne) | 2022 | https://conductscience.org/library/papers/36844955 | PubMed |
| 36012449 | A Hybrid Epithelial to Mesenchymal Transition in Ex Vivo Cutaneous Squamous Cell Carcinoma Tissues. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012449 | PubMed |
| 35454779 | Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: The Current and Future Role of Radiation Therapy in the Era of Immunotherapy. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35454779 | PubMed |
| 33925915 | Advances in Targeting Cutaneous Melanoma. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/33925915 | PubMed |
| 33558963 | An online review of informational sources for advanced or high-risk cutaneous squamous cell carcinoma. | Support Care Cancer | 2021 | https://conductscience.org/library/papers/33558963 | PubMed |
| 33126349 | Anti-PD-1 antibody therapy for epithelial skin malignancies: An investigator-initiated, open-label, single-arm, multicenter, phase II clinical trial (NMSC-PD1 Study). | Medicine (Baltimore) | 2020 | https://conductscience.org/library/papers/33126349 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32004792
GET https://conductscience.org/api/papers/v1/32004792/authors?page=2